Speaker of the House Nancy Pelosi wears a mask on Capitol Hill on April 30. Members in the House will not return over coronavirus fears but the Senate is scheduled to return on Monday.; Credit: Saul Loeb/AFP via Getty Images

House Speaker Nancy Pelosi and Senate Majority Leader Mitch McConnell, in a rare joint statement on Saturday, declined an offer from the White House to make rapid COVID-19 tests available for Congress.

"Congress is grateful for the Administration's generous offer to deploy rapid COVID-19 testing capabilities to Capitol Hill, but we respectfully decline the offer at this time," Pelosi and McConnell said. "Our country's testing capacities are continuing to scale up nationwide and Congress wants to keep directing resources to the front-line facilities where they can do the most good the most quickly."

McConnell, R-Ky., plans to bring the Senate back into session on Monday, while Pelosi, D-Calif., and House Majority Leader Steny Hoyer, D-Md., said this week the House would not bring representatives back over coronavirus fears.

On Friday, Health and Human Services Secretary Alex Azar said on Twitter that the Trump administration would send three Abbott "point of care testing machines and 1,000 tests for their use" to Capitol Hill.

President Trump on Saturday tweeted: " No reason to turn it down, except politics. We have plenty of testing. Maybe you need a new Doctor over there. Crazy Nancy will use it as an excuse not to show up to work!"

Pelosi and Hoyer said they made the decision based on advice from the Capitol's attending physician, Brian Monahan. "The House physician's view was that there was a risk to members that was one he would not recommend taking," Hoyer said Tuesday.

So far, Rand Paul of Kentucky is the only senator to have tested positive for the coronavirus. In the House, seven members have tested positive or presumed to be positive for the coronavirus.

On Friday, McConnell shared guidelines from Monahan urging lawmakers and staff to maintain six feet of distance, limit the number of people in offices and to wear masks when possible.

Monahan has told Republican leaders that his office does not have the capacity to proactively test all 100 senators and can only test those who are ill, Politico reported.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Losing your smartphone can be expensive, but the cost of the device may not be the final price you’ll be paying

The post What to do you if your phone is lost or stolen appeared first on WeLiveSecurity

The email includes the potential victim’s password as evidence of a hack, but there is more than meets the eye

The post Sextortion scammers still shilling with stolen passwords appeared first on WeLiveSecurity

Source: Streetwise Reports   05/05/2020

Commercial-stage biotechnology company Portola Pharmaceuticals Inc. (PTLA:NASDAQ), which focuses on blood-related disorders, and global biopharmaceuticals firm Alexion Pharmaceuticals Inc. (ALXN:NASDAQ) announced that they have entered into a definitive merger agreement for Portola to be acquired by Alexion.

The acquisition is said to provide a key addition to Alexion's diversified commercial portfolio. The report indicated that the merger agreement has already been unanimously approved each of the company's boards of directors.

The report explained that "Portola's commercialized medicine, Andexxa^® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed as Ondexxya^® in Europe, is the first and only approved Factor Xa inhibitor reversal agent, and has demonstrated transformative clinical value by rapidly reversing the anticoagulant effects of Factor Xa inhibitors rivaroxaban and apixaban in severe and uncontrolled bleeding."

Portola's President and CEO Scott Garland commented, "In developing and launching Andexxa, Portola has established a strong foundation for changing the standard of care for patients receiving Factor Xa inhibitors that experience a major, life-threatening bleed. Andexxa rapidly reverses the pharmacologic effect of rivaroxaban and apixaban within two minutes, reducing anti-Factor Xa activity by 92 percent...Given their enhanced resources, global footprint and proven commercial expertise, we look forward to working with Alexion to maximize the value of Andexxa. With their commitment to commercial excellence, together, we will be able to drive stronger utilization of Andexxa, increase penetration and accelerate adoption in the critical care setting."

Ludwig Hantson, Ph.D., CEO of Alexion, remarked, "The acquisition of Portola represents an important next step in our strategy to diversify beyond C5. Andexxa is a strategic fit with our existing portfolio of transformative medicines and is well-aligned with our demonstrated expertise in hematology, neurology and critical care...We believe Andexxa has the potential to become the global standard of care for patients who experience life-threatening bleeds while taking Factor Xa inhibitors apixaban and rivaroxaban. By leveraging Alexion's strong operational and sales infrastructure and deep relationships in hospital channels, we are well positioned to expand the number of patients helped by Andexxa, while also driving value for shareholders."

The firms advised that "under the terms of the merger agreement, a subsidiary of Alexion will commence a tender offer to acquire all of the outstanding shares of Portola's common stock at a price of $18 per share in cash." Alexion plans to fund the purchase with existing cash on hand and the transaction is expected to close in Q3/20. The purchase is subject to approval by a majority interest of Portola's common stockholders tendering their shares along with ordinary closing conditions and regulatory approvals. The company noted that "following successful completion of the tender offer, Alexion will acquire all remaining shares not tendered in the offer at the same price of $18 per share through a merger."

Alexion is a global biopharmaceutical company based in Boston, Mass., with offices in 50 countries worldwide. The company states that it has been "the global leader in complement biology and inhibition for more than 20 years and that it has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis and neuromyelitis optica spectrum disorder."

Portola is headquartered in South San Francisco, Calif., and is a commercial-stage biopharmaceutical company focused on treating patients with serious blood-related disorders. Specifically, the company is engaged in developing and commercializing novel therapeutics in order to advance the fields of thrombosis and other hematologic conditions. The firm listed that its first two commercialized products are Andexxa^® and Bevyxxa^® (betrixaban), and that it is also advancing and developing cerdulatinib, a SYK/JAK inhibitor for use in treatment of hematologic cancers.

Portola Pharmaceuticals started off the day with a market capitalization of around $609.0 million with approximately 78.5 million shares outstanding and a short interest of about 23.0%. PTLA shares opened 130% higher today at $17.85 (+$10.09, +130.03%) over yesterday's $7.85 closing price. The stock has traded today between $17.71 and $17.91 per share and is currently trading at $17.83 (+$10.07, +129.77%).

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.

A hacking group has started to flood a dark web hacking marketplace with databases containing a combined total of 73.2 million user records over 11 different companies. [...]

Paleontologists with the Burke Museum of Natural History and Culture and the University of Washington have discovered a Tyrannosaurus rex, including a very complete skull. The find, which paleontologists estimate to be about 20 percent of the animal, includes vertebrae, ribs, hips and lower jaw bones.

read more

Jobs are also expected to nosedive in the remaining quarters of the year unless demand picks up by the festive season later this year, experts tracking the sector said. Travel, hospitality, tourism, aviation, retail, outdoor entertainment, food and beverages and real estate sectors have been hit the most, staffing agency TeamLease said.

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

BRISTOL – In an effort to keep motorists informed, the Virginia Department of Transportation (VDOT) provides weekly information about highway...

The post ‘Golden goose’ of salt tolerant wheat varieties to begin field trials appeared first on The Lead SA.

This file is in PDF format, requiring the Adobe Acrobat Reader to open.

A new study shows that coral reef-building is more complex than Darwin thought.

Climate change has already taken a serious toll on human well-being and world economies.

An art student inspired by "clean eating" creates ephemeral fruit mandalas that are as tasty as they are beautiful.

With an estimated price tag of nearly a billion dollars, the 7-mile bike highway would help alleviate London's traffic and air pollution woes.

Thieves make off with $20,710 worth of the sweet hazelnut spread.

Anas Cheema, a 22-year-old economics student at the University of Victoria, decided to dedicate his summer.

The NOAA suspects the infectious morbillivirus is responsible for the unusually high number of dolphin strandings and deaths this month.

The pilfering of e-mail correspondence among climate scientists from a major climate center in Britain two weeks ago has grown into a very public controversy un

After nearly 100 years of burning coal to heat and cool Congress, the U.S. Capitol Power Plant will switch over to less harmful natural gas.

Filmmaker Mark Kitchell talks to MNN about the need to understand the birth and life of the green movement in the U.S.

The end has come for new stories about Middle-earth, but there will never be an end to how they will inspire.

If you've never tried a Carmenere before, Lapostolle’s Alexandre Cuvee Carmenere would be a great bottle to start with.

These before-and-after shots perfectly capture the moment a compliment is received.

The Aldabra banded snail was believed to have been driven to extinction by climate change, but researchers have found a few stragglers.

Maybe it's time to rethink the rules of water warfare and retreat to the age of squirt guns and water balloons.

New evidence suggests this same story has been passed on for 37,000 years.

Prehistoric humans missed animals when they disappeared and even wondered how to get them back.

Lush, but low-water gardens are a growing popular necessity around the world, and the Australians have a lot to teach the rest of the world.

How many mentors do you have? Many people swear by their mentors and frequently credit them with much of their success. In this article you will find out not only what to look for in a mentor, but also how to find mentors, and why you should have many instead of just one.

Citations Twitter Read more articles like this. More information like this. Keywords: Live collagen for baby boomers, Collagen anti wrinkle cream, Most effective anti wrinkle cream, The best collagen cream, What is collagen, Collagen cream for face. Graphics: Share This

The post What Do Dermatologists Have to Say About Drinkable Sunscreen? appeared first on RSS News Feed.

Prove yourself as a quality, hard-working, safe, reliable driver and get to know as many people in the chain of command as you can. You don't have to be a kissy-ass, but just get to know them, show them respect, and do an awesome job for them.

This article explains about the procedures one might take in the event of a missing/stolen cell phone, to avoid unauthorized charges made by third parties. Also it talks about reporting to government agencies to guarantee consumer rights.

Amateur archaeologist and historian Ronald Bodtcher creates the WanderingBoulder.com website to document his discovery and to analyze the boulder's Fremont Indian, Mormon Pioneer and Spanish Explorer markings.

Dr. Langdon won eight Patients' Choice Awards between 2011 and 2018

Collectible Pistols From Outer Space

Dr. Villa dedicates her research to the elderly and veteran populations and also serves as a professor for California State University

More than 100 members of The Georgia Society of Certified Public Accountants (GSCPA) recently met at the state Capitol with their elected officials.

Doni-Jo Minor-Munro, Yuchi tribal member is a Traditional Spiritual Healer who currently serves as Director of Urban Indian Education in Santa Barbara Tri-County area California.

"Pebble Mine: The Changing Minds" Keynote Panel set to provide an in-depth discussion of the recent Army Corp of Engineers' Draft Environmental Impact Statement on Pebble Mine Development in Bristol Bay at 2019 Pacific Marine Expo.

Shorr Packaging supports the bi-partisan Pro-ESOP Bills H.R.2258 and S.177 – Promotion and Expansion of Private Employee Ownership Act.

Dr. Shelley has been the recipient of accolades from the Women's Dermatologic Society, including the Rose Hirschler Award in 2007 and the Walter B. Shelley MD Leadership Award in 2012

Follow these steps for proper hand care before, during and after work to help reduce 90% of work-related skin disorders

These are times of great social and political upheaval and unrest. Divisiveness runs rampant and harmful rhetoric is the order of the day. One determined, modern character wants to make changes where they're needed most.